抗微生物A4K14-Citropin的基合修饰和抗癌活性 1.1
Huaxing Shen1, Nan Zhang1, Xianglong Kong2
1School of Medicine, Shanghai University, Shanghai 200444, China.
Bioorganic & medicinal chemistry letters
|October 7, 2023
概括
合成了A4K14-Citropin 1.1的基合衍生物,这是一个有前途的抗癌. 这些新型化合物显示出增强的螺旋性和强大的抗癌活性,具有最小的溶血效应,表明新药开发的潜力.
科学领域:
- 生物化学 生化学
- 类化学 类化学
- 药理学 药理学是指药理学的学科.
背景情况:
- A4K14-Citropin 1.1是一种衍生抗微生物 (AMP),具有抗癌潜力.
- 像A4K14-Citropin 1.1这样的线性通常由于二次结构不稳定而患有不良的药物动力学特性.
研究的目的:
- 设计和合成A4K14-Citropin的基结合衍生物 1.1.
- 为了评估这些新型接的物理,化学和生物特性.
主要方法:
- 一系列 A4K14-Citropin 的基合衍生物的合成 1.1.
- 评估二次结构稳定性 (螺旋性) 和抗癌活性.
- 对溶血效应的评估,以确定安全性.
主要成果:
- 与原型相比,合,特别是AC-CCSP-2-o和AC-CCSP-3-o,表现出增加的螺旋性.
- AC-CCSP-2-o和AC-CCSP-3-o表现出增强的抗癌活性.
- 在压缩和原型之间没有观察到血液溶解活性的显著差异.
结论:
- A4K14-Citropin 1.1的基合衍生物在解决结构稳定性的同时保持或改善抗癌疗效.
- AC-CCSP-2-o和AC-CCSP-3-o是开发新型抗癌疗法的有希望的化合物.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


